25 September 2020 - Deborah Wilkes
Premium
Germany’s Neuraxpharm will soon have a new private-equity owner. Permira has agreed to acquire the pharmaceutical company specialising in central nervous system (CNS) products from Apax Partners for an undisclosed sum.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.